Opposition Brief — Nescco, Inc. v. United States
Supreme Court brief1987
Ask Donna
What actually matters in this document.
Text
| 9a the Suprewe Court of the United States
OCTOBER TERM, 1986
.
- NESCCO, INC., AND BALARAMA’S ENTERPRISES,
“ING, PETITIONERS
v.
- rk _ *. “ee
°
UNITED STATES OF AMERICA
)
ON PETITION FOR.A WRIT OF CERTIORARI TO THE
UNITED STATES COURT OF APPEALS
FOR THE NINTH CIRCUIT
MEMORANDUM FOR THE UNITED STATES
IN OPPOSITION
CHARLES FRIED
Solicitor General
‘ Department of Justice
Washington; D.C. 20530
(202) 633-2217
\\ p?
TABLE OF AUTHORITIES
Cases: Page
Andresen V. Maryland, 427 U.S. 463 (1976) ........ 5, 6, 7,9
Milliman v. Minnesota, 774 F.2d 247 (8th Cir.
EPIRA SRSA SIRS cr ee) na or 9
United States v. Abrams, 615 F.2d 541 (1st Cir.
SERA RIN en. 9
United States v. Gomez-Soto, 723 F.2d 649 (9th
Cir.), cert. denied, 466 U.S. 977 (1984) ............. 9
United States v. Jacob, 657 F.2d 49 (4th Cir.
1981), cert. denied, 455 U.S. 942 (1982) ............. 9
United States v. Johnson, 690 F.2d 60 (3d Cir.
1982), cert. denied, 459 U.S. 1214 (1983) ............ 9
United States v. Pollock, 726 F.2d 1456 (9th Cir.
| ERR SH 2h REA NS ST ga recat 2 I 8
United States vy. Roche, 614 F.2d 6 (1st Cir. 1980) .. 9
United States v. Wuagneux, 683 F.2d 1343 (11th
Cir. 1982), cert. denied, 464 U.S. 814 (1983)...... 9
Constitution and Statutes:
Te IIIS DEW asscoanctdocndstenttninseessininnonctnenninnion 1, 6, 7, 8, 9
I aa a cenilapnbtubeioiuannal 5
REESE aettnordas hee a 1,4
RRNA er 1,4
ee ee I OD CN ce scssencnsstcsnconscnnensies 2
Bt ER ae el 2
(1)
Iu the Supreme Court of the United States
OCTOBER TERM, 1986
No. 86-883
‘NESCCO, INc., AND BALARAMA’S ENTERPRISES,
INC., PETITIONERS
Vv.
UNITED STATES OF AMERICA
ON PETITION FOR A WRIT OF CERTIORARI TO THE
UNITED STATES COURT OF APPEALS
FOR THE NINTH CIRCUIT
MEMORANDUM FOR THE UNITED STATES
IN OPPOSITION
Petitioners contend that a search warrant executed
by the Food and Drug Administration (FDA) vio-
lated the Fourth Amendment’s requirement of par-
ticularity.
1. This case arose out, of the FDA’s investigation
of petitioners, who allegedly were manufacturing and
marketing cocaine substitutes in violation of 21
U.S.C. 331(a) and (k). Section 331 prohibits the
following acts:
(1)
2
(a) The introduction or delivery for introduc-
tion into interstate commerce of any * * * drug
* * * that is misbranded.
* * * * *
(k) * * * the doing of any * * * act with
respect to, a * * * drug * * *, if such act is done
while such article is held for sale (whether or
not the first sale) after shipment in interstate
commerce and results in such article being * * *
misbranded.
In the FDA’s view, marketing cocaine substitutes
without specifying the active ingredients of the sub-
stances (see 21 U.S.C. 352(e) (1) (A) (ii) ), or with-
out providing adequate directions for the use of the
substances (see 21 U.S.C. 352(f)(1)), constitutes
the misbranding of drugs, in violation of Section 331.
In 1983, the State of California enjoined petitioner
Balarama’s Enterprises, Inc., from manufacturing,
packaging, marketing, selling, or distributing Benzo-
caine, Lidocaine, Tetracaine, and Procaine—anes-
thetic drugs often diverted to illegal use as cocaine
substitutes (Pet. App. A5). The injunction had little
practical effect, however, as the FDA learned when
an employee of Balarama’s, arrested for possession
of cocaine, was found with roughly 2000 leaflets from
Balarama’s entitled “Cocaine.” Each leaflet stated
that the product advertised was a synthetic substitute
for cocaine. Jd. at A5-A6. The FDA obtained a copy
of petitioner’s catalogue, which listed many items for
sale as incense with commercial names suggesting
that the incense was to be used as a cocaine substi-
tute. Some of the products even bore a label stating,
“if ingested or inhaled, may cause stimulation.” Jd.
at A6. An agent of the FDA placed orders with and
ee
3
received from Balarama’s some of these cocaine sub-
stitutes (id. at A8).
To further its investigation, the FDA in 1984 de-
cided to search Balarama’s principal place of busi-
ness, as well as a warehouse leased in the name of
NESCCO, which the FDA had learned operated as
an alter ego of Balarama’s (Pet. App. A9). Based
on affidavits by an FDA inspector detailing the infor-
mation the FDA possessed regarding Balarama’s ac-
tivities, the FDA obtained warrants to search both
premises.’ Items 1 through 14 in the search war-
rants listed 14 different drugs that were used as co-
caine substitutes (see id. at A15-A16, A18-A19).
Item 15 (id. at A16, A19-A20) provided for the
seizure of:
All other articles of drug (which include com-
ponents of drugs); labeling for drugs; orders
for drugs received in the mail and any checks or
money orders contained therein; records of or-
ders for drugs received by telephone; receiving
-and shipping records for drugs and drug mate-
rials; all other reeords, including telephone rec-
ords and computerized records, which may re-
flect the purchasing, ordering, sale, repacking,
distribution, or other disposition of drugs; checks
from U.P.S. for C.0.D. shipments of drugs; per-
sonal or business correspondence relating to the
purchasing, ordering, sale, repacking, distribu-
tion, or other disposition of drugs; and other
fruits and instrumentalities of crimes which are
evidence of violations of, or in violation of, 21
U.S.C. 331(a) and (k).
1 Petitioners have not challenged the court of appeals’
determination that the FDA established probable cause for
the search.
4
In executing the warrants at both premises, United
States marshals seized a large quantity of substances
that they believed were intended to be used as cocaine
substitutes. The marshals also seized business records
relating to transactions in those drugs. Pet. Supp.
App. A22, A24-A27. The business records were sub-
sequently returned (id. at A22). No criminal
charges are currently pending against petitioners (id.
at A21-A22).
b. On December 6, 1984, petitioners moved in dis-
trict court for return of the seized property that the
FDA had not already returned.? The district court
denied the motion, holding that the FDA had estab-
lished probable cause to believe that 21 U.S.C. 331 (a)
and (k) had been violated. The court concluded that
the magistrate “properly issued a warrant to search
for and seize items identical to those purchased by
the FDA agents, those lawfully observed by affiant,
and generic items for which objective articulable
standards were provided. The numerous items found
on the premises, whether specifically identified in the
warrant or clearly falling within the generic cate-
gory articulated in section 15 of that document, were
properly seized.” Pet. Supp. App. A22 (citation
omitted),
The court of appeals affirmed, holding that the
warrants were sufficiently particularized to meet con-
stitutional standards. The court noted that items 1
through 14 “consist of fourteen different items which
might be drugs identified by the names given in a
Balarama’s catalog sent to Agent Pierkarski. Such
descriptions are obviously sufficiently particularized”
(Pet. App. A10). The only remaining question was
2 The property retained by the FDA consisted of the drugs,
cartons, and labels listed in Pet. Supp. App. A24-A27 (id.
at A22).
5
whether item 15, which authorized the seizure of
drugs, labels, business records, and “other fruits and
instrumentalities of crimes which are evidence of vio-
lations of * * * 21 U.S.C. 331(a) and (k),” met the
Fourth Amendment standard of particularity.
While the court commented that the question was
a “close one” (Pet. App. A10), it held that the war-
rants as a whole satisfied the particularity require-
ment, The court initially noted that the statutory
limitation in item 15, restricting the search to the
fruits or instrumentalities of a violation of 21 U.S.C.
331, did not in and of itself provide a sufficient limi-
tation. In the court’s view, “where a statute provides
the only limitation on a search, the executing officers
are forced to interpret the statute in limiting their
search, a task they may be unqualified to perform.”
Pet. App. at All. The court held, however, that
item 15 must be considered in the context of the
framework set by items 1 through 14. Relying upon
Andresen v. Maryland, 427 U.S. 468, 480-482 (1976),
the court stated (7d. at A12) that
item 15 cannot be read in a vacuum and must
instead be construed in light of the presence of
items 1-14. Because items 1-14 provide a sample
of names of suspected misbranded drugs, we be-
lieve that they implicitly limited item 15’s other-
wise unbounded reference to all other drugs
(and labeling and paperwork relating to drugs)
to only those drugs with names of the same
nature as those identified in items 1-14.
The court further explained that the government
could not have specified the precise names of all the
drugs that were likely to be misbranded, since the
government would have no way of knowing all the
street names that could be used for the cocaine sub-
6
stitutes (Pet. App. Al8). The court concluded, there-
fore, that the warrants as a whole provided sufficient
guidelines for the officers serving the warrants and
thus were consistent with constitutional standards.
2. Petitioners contend that the Ninth Circuit’s
‘implied limitation” rule of particularity sanctions
the use of general warrants and is thereby incon-
sistent with the Fourth Amendment. In addition,
petitioners assert that the decision below creates a
conflict among the circuits.
a. Far from articulating a “novel standard” (Pet.
7) or one that is “freshly coined” (Pet. 6), the court
of appeals simply applied the approach used by this
Court in Andresen v. Maryland, 427 U.S. 463 (1976).
There, state law enforcement officials carried out an
investigation of petitioner’s real estate settlement
activities. The officials procured search warrants for
petitioner’s offices, detailing various items to be seized
in connection with petitioner’s role in the conveyance
of Lot 13T, a particular parcel in a real estate devel-
opment project. While petitioner conceded that the
warrants were for the most part “models of particu-
larity” (427 U.S. at 479), he argued that they were
rendered fatally general by the addition of the phrase
“together with other fruits, instrumentalities and
evidence of crime at this [time] unknown.” That
phrase was included in the warrant at the end of a
comprehensive list of items to be seized. As in this
ease, the defendant in Andresen argued that the final
phrase should be read in isolation from the other
parts of the warrants, and that standing apart the
phrase would have permitted the seizure of items that
were evidence of any conceivable crime. This Court
rejected that argument. It held instead that the final
phrase should be read in context with the full text of
7
the warrants, which authorized the search for and
seizure of material relevant only to petitioner’s activ-
ities in connection with Lot 13T. So construed, the
Court held that the warrants comported with Fourth
Amendment standards of particularity. 427 U.S. at
479-482. :
The court of appeals in this case adopted a similar
tack. The court construed item 15 in the warrants,
which authorized the seizure of drugs, labels, and
paperwork, to refer only to the types of drugs listed
in items 1 through 14. Just as the language “to-
gether with other fruits, instrumentalities and evi-
dence of crime at this [time] unknown” in Andresen
was interpreted to be limited to evidence of the crime
of false pretenses with respect to Lot 13T, so the
search and seizure authorized in item 15 was limited
to cocaine substitutes of the type listed in items 1
through 14, along with the components and labels for
those drugs. The list of drugs in items 1 through 14
therefore provided the officers serving the warrants
with sufficient guidelines to determine which items to
seize.
The court of appeals properly noted that it would
be unrealistic to hold the government to a standard
of much greater precision. While the government
was aware of many of the street names used for co-
caine substitutes, the court found that government
agents could not have foreseen all the names that pe-
titioners might have given to the cocaine substitutes.°
* Petitioners point out (Pet. 12) that the affidavits in sup-
port of the search warrants named and referred to 57 differ-
ent product items while only 14 were listed in the warrants
themselves. Yet petitioners do not contest that the 14 drugs
listed were sufficient to apprise those serving the warrants
of the type of drug to be seized. Nor do they dispute that it
8
Thus, items 1 through 14 were as precise as they
could practically be, by providing a list of the most
common “chemical names and street-slang terminol-
ogy often associated with cocaine or cocaine substi-
tutes” (Pet. App. A18). As the Ninth Circuit has
previously observed, “[s]o long as officers can distin-
guish between legally and illegally possessed property
on the basis of objective, articulated standards, a
search warrant based on probable cause may direct
inspection of premises containing a generic class of
items, a portion of which are believed to be stolen or
contraband.” United States v. Pollock, 726 F. 2d
1456, 1466 (1984) .*
In sum, the Ninth Circuit correctly construed this
Court’s decision in Andresen to hold that an other-
wise overbroad authorization for a search is suff-
ciently particularized if, in the context of the entire
warrant, there are reasonably objective standards to
govern the executing officers’ search. As applied in
this case, the limitations contained in items 1 through
14, namely that the misbranded drugs be those in-
tended to be used as cocaine substitutes, provided the
requisite standards to satisfy the requirements of the
Fourth Amendment.
b. Nor does the court’s opinion, as petitioners sug-
gest (Pet. 9), give rise to a split among the circuits.
would have been impossible for the government to have pre-
pared a comprehensive list of the wide variety of merchandis-
ing names used to identify different cocaine substitutes.
* Petitioners assert (Pet. 13) that the marshals seized items
that were not similar to those enumerated in items 1 through
14. The warrants, however, also authorized the seizure of
the “components of drugs” and “labeling for drugs,” which
would include, inter alia, cutting and packaging agents of the
sort cited by petitioners. See Pet. Supp. App. A24-A27.
9
While petitioners are correct that some courts of ap-
peals have held that limiting a search to items that
are evidence of the violation of a certain statute is
generally not specific enough, see, ¢.g., United States
v. Gomez-Soto, 723 F.2d 649 (9th Cir.), cert. denied,
466 U.S. 977 (1984); United States v. Roche, 614
F.2d 6 (1st Cir. 1980), the cases cited by petitioner
do not hold that such searches violate the Fourth
Amendment if the rest of the warrant in effect pro-
vides standards circumscribing the discretion of the
searching officers. Indeed, the courts of appeals have
agreed with the Ninth Circuit in applying Andresen
so that “the ‘general’ tail of the search warrant will
be construed so as not to defeat the ‘particularity’ of
the main body of the warrant.” United States v.
Abrams, 615 F.2d 541, 547 (1st Cir. 1980). See also
Milliman v. Minnesota, 774 F.2d 247, 250 (8th Cir.
1985) (“Of course whether a warrant fails the par-
ticularity requirement cannot be decided in a vacuum.
The court will base its determination on such factors
as the purpose for which the warrant was issued, the
nature of the items to which it is directed, and the
total circumstances surrounding the case.”) (citation
omitted) ; United States v. Wuagneux, 683 F.2d 1348,
1349-1351 (11th Cir. 1982), cert. denied, 464 U.S. 814
(1983) ; United States v. Jacob, 657 F.2d 49, 51-52
(4th Cir. 1981), cert. denied, 455 U.S. 942 (1982) ;
United States v. Johnson, 690 F.2d 60, 64 (38d Cir.
1982), cert. denied, 459 U.S. 1214 (1983).
It is therefore respectfully submitted that the pe-
tition for a writ of certiorari should be denied.
CHARLES FRIED
Solicitor General
JANUARY 1987 ;
WX oU. S. GOVERNMENT PRINTING OFFiCcE; 1987 181483 40199
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.